Actively Recruiting
Evaluation of Valvular Heart Disease Using Cardiac CT
Led by Toho University · Updated on 2025-05-14
350
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis. 1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients. 2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD. 3. Monitoring serial changes in VHD severity via echocardiography. 4. Investigating the relationship between echocardiographic and CT-derived parameters. 5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.
CONDITIONS
Official Title
Evaluation of Valvular Heart Disease Using Cardiac CT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with at least moderate valvular heart disease who had a cardiac CT with 64 or more rows
- 18 years of age or older
You will not qualify if you...
- Less than 18 years old
- Acute valvular heart disease
- Infectious endocarditis
- Patients with post-valvular heart disease intervention
- Poor cardiac CT image quality for analysis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Toho University
Ōta-ku, Tokyo, Japan, 143-8540
Actively Recruiting
Research Team
H
Hideki Koike, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here